"What" Series

What is Health-related Quality of Life (HRQoL) in Clinical Trials?

16 October 2023
2 min read

Health-Related Quality of Life (HRQoL) is a significant indicator for assessing the quality of life and health status of patients. Quality of life is usually used as a secondary clinical endpoint to compare treatment methods with similar effects and varying toxicity. However, it can also be paired with Overall Survival (OS) as a co-primary endpoint. HRQoL is typically assessed through a set of four core questions developed by the U.S. Center for Disease Control and Prevention (CDC), which includes overall health, physical health, mental health, and daily life activities.

Circular RNA: A Gene Therapy Alternative to mRNA
Advanced Tech.
4 min read
Circular RNA: A Gene Therapy Alternative to mRNA
16 October 2023
Circular RNA (circRNA) is a type of single-stranded RNA with a closed loop structure, initially found in HDV and plant viruses.
Read →
Vedanta Biosciences Reports Initiation of Phase 2 l Study for VE202 in Ulcerative Colitis
Latest Hotspot
3 min read
Vedanta Biosciences Reports Initiation of Phase 2 l Study for VE202 in Ulcerative Colitis
16 October 2023
Vedanta Biosciences recently reported the initiation of treatment for the initial participant in the COLLECTiVE202 Phase 2 investigation of VE202.
Read →
What is Clinical Benefit Rate (CBR) in Clinical Trials?
"What" Series
2 min read
What is Clinical Benefit Rate (CBR) in Clinical Trials?
16 October 2023
Clinical Benefit Rate (CBR) is defined as the percentage of advanced cancer patients who achieve complete remission, partial remission, or at least six months of stable disease after treatment.
Read →
BridgeBio and Resilience declares a collaboration aiming to progress BBP-631, BBP-812
Latest Hotspot
3 min read
BridgeBio and Resilience declares a collaboration aiming to progress BBP-631, BBP-812
16 October 2023
BridgeBio Pharma and National Resilience Inc., which focus on genetic diseases, cancer pharmaceuticals, and tech-driven biomanufacturing respectively, announced a partnership to develop and produce BBP-812 and BBP-631, gene therapies for Canavan disease and congenital adrenal hyperplasia.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.